Meyka Pro banner
iSpecimen Inc.

iSpecimen Inc. (ISPC) Stock Overview

Explore iSpecimen Inc.’s financial performance, market position, analyst ratings, and future outlook.

ISPCNASDAQ
HealthcareMedical - Diagnostics & Research
$1.92
$0.23(10.70%)
U.S. Market opens in 13h 59m

iSpecimen Inc. (ISPC)

Meyka AI Score

Z

Key Financials

Market Cap265.2K
P/E Ratio-0.01
EPS (TTM)$-31.16
ROE-5.85%
Fundamental Analysis

AI Price Forecasts

1 Month$2.32
3 Months$5.01
1 Year Target$8.71

ISPC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of iSpecimen Inc. (NASDAQ: ISPC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, iSpecimen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ISPC on the NASDAQ shows an RSI of 41.00, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $8.71 for the NASDAQ listing.

Key metrics behind iSpecimen Inc.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 265.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of ISPC on the NASDAQ.

Price Performance (NASDAQ: ISPC)

1-Day Change
-11.16%
5-Day Change
1.06%
1-Month Change
-25.68%
3-Month Change
-67.79%
6-Month Change
-86.16%
Year-to-Date (YTD) Change
-81.63%
1-Year Change
-96.71%
3-Year Change
-99.81%
5-Year Change
-99.96%
All-Time (Max) Change
-99.97%

Contact Information

781 301 6700
8 Cabot Road, Woburn, MA, 01801

Company Facts

70 Employees
IPO DateJun 17, 2021
CountryUS
Actively Trading

Frequently Asked Questions